Aspira Womens Health Inc.

1.73 USD
+0.08 (+4.85%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Aspira Womens Health Inc. stock is down -25.75% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 23 June’s closed higher than May.

About Aspira Womens Health Inc.

Aspira Women's Health Inc. engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVAInherit tests to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of Gynecologic cancer.